Qingyu Luo, MD, PhD
Qingyu earned his medical degree in clinical medicine from Dalian Medical University, where he first developed a passion for unraveling the complexities of cancer biology. During his PhD at Peking Union Medical College—the top-ranked medical school in China—he completed over 10 collaborative translational research projects as a team leader and was awarded the Dean’s Award, granted to only 13 out of 1,300+ graduates. While at Dana-Farber Cancer Institute, Qingyu pioneered a method to convert complex biological features into predictive biomarkers for leukemia treatment response, alongside an ex vivo culture system for testing drug sensitivity from fresh patient samples. These breakthroughs, published in Nature, led to a clinical trial and earned him a faculty appointment at Harvard Medical School. As the co-founder of One Patient One Cure, Qingyu merges his expertise in medicine and biology with artificial intelligence to realize a new era of personalized, accessible, and cost-effective healthcare.
Email: qingyu.luo@onepatientonecure.org
Co-founder
President
Humam Zaman
Humam is a pioneering AI entrepreneur and CEO of The Tech Valley, where he leads a multidisciplinary team of 20+ professionals—spanning machine learning, NLP, blockchain, data science, UI/UX, and software engineering. He has successfully delivered more than 140 AI-powered projects across various sectors, including healthcare, and has collaborated with major organizations such as Google, Hugging Face, OpenAI, and Mayo Clinic. His strategic engagements include national-level consulting in New Zealand’s public sector. In addition to overseeing technical direction, Humam drives team growth, business strategy, and client success. As co-founder and interim technical officer of One Patient One Cure, he leads development of the organization’s AI predictor models, while also serving as Vice President of Global Outreach to advance the mission internationally.
Email: humam.zaman@onepatientonecure.org
Co-founder
Vice President of Global Outreach
Anthony R. Franco, JD
Anthony brings over 20 years of experience bridging legal, operational, and biotech domains. As Chief Operating Officer and Co-Founder of ReST Therapeutics US, he leads fundraising, product development, and regulatory strategy. His prior executive roles at Infinant Health and Alexion Pharmaceuticals included managing global operations, capital planning, and digital transformation initiatives. With deep expertise in commercialization, long-term planning, and systems implementation, Anthony is also a passionate advocate for diversity and team empowerment. His ability to scale infrastructure and align cross-functional teams supports One Patient One Cure in growing sustainably while staying true to its mission.
Email: anthony.franco@onepatientonecure.org
Barbara Hales, MD
Barbara contributes a rare dual perspective as both a seasoned physician and a skilled communicator. With over 30 years of clinical experience in Obstetrics and Gynecology and a thriving career as a medical writer and content strategist, she bridges the gap between science and storytelling. She is the author of Power to the Patient: The Medical Strategist and EMR Guide—Choosing Without Losing, and served as editor of The Medical Strategist newsletter. She now produces the podcast "Marketing Tips for Doctors" where she helps physicians promote themselves. Her ability to make complex medical topics accessible ensures that One Patient One Cure maintains clear, compassionate communication while advancing AI-driven precision medicine.
Email: barbara.hales@onepatientonecure.org
Henry Hagopian
Henry brings a wealth of financial expertise shaped by more than 30 years in biotech, healthcare, and technology. He has held senior leadership roles including CFO of Annovis Bio and SVP at Organogenesis, where he navigated IPOs, SEC reporting, major fundraising rounds, and M&A activity. His experience includes negotiating high-value credit facilities, enhancing investor relations, and leading enterprise-wide financial systems upgrades. With both Wall Street acumen and operational execution skills, Henry ensures that One Patient One Cure has the financial discipline and resilience to support its ambitious vision.
Email: henry.hagopian@onepatientonecure.org
Deepa Kushwaha, PhD
Deepa is a scientific powerhouse with extensive expertise in cancer biology and rare disease research. A former research fellow at Dana-Farber Cancer Institute and Harvard Medical School, she has led pivotal studies on DNA repair, glioblastoma, and drug resistance. Her background includes next-generation sequencing, precision oncology, and biomarker development. As Scientific Director at the Rare Genomics Institute and a Senior Scientific Writer at Champions Oncology, she has overseen research strategy, IND preparation, and scientific communications. Her deep understanding of translational science ensures that One Patient One Cure remains grounded in rigorous, real-world data.
Email: deepa.kushwaha@onepatientonecure.org
Director
Director
Director
Director
Tyler Goodwin, PhD
Tyler is a seasoned biotechnology and pharmaceutical leader with extensive experience leading innovation in gene and cell therapy, molecular pharmaceutics, and clinical-stage product development. As the Head of Delivery and Development at Tune Therapeutics, Tyler has successfully led cross-functional teams in advancing gene delivery technologies, optimizing RNA, DNA, and vector systems, and ensuring scalable production. His leadership extends to consulting roles with Biotechlogic/Dark Horse Consulting, where he has guided global clients in gene and cell therapy manufacturing and regulatory compliance. With a proven track record of driving scientific excellence, building strategic partnerships, and bringing transformative therapies to patients, Tyler provides invaluable leadership to One Patient One Cure's mission of accelerating precision medicine for all.
Email: tyler.goodwin@onepatientonecure.org
Director
Rex Kantatan
Rex brings over a decade of experience in oncology, healthcare leadership, and medical education. He currently serves as the Lead Radiation Therapist at Dartmouth Cancer Center's Department of Radiation Oncology and Applied Sciences. His experience provides frontline insight into patient care and clinical outcomes. In addition to his clinical role, Rex contributes as a department policy writer and serves as a clinical liaison for both the University of Vermont and New Hampshire Technical Institute. Committed to community engagement, Rex is actively involved in fundraising and outreach initiatives. He also operates a music entertainment enterprise that supports local events and nonprofit efforts. His expertise in precision cancer treatment and dedication to individualized care align closely with the mission of One Patient One Cure.
Email: rex.kantatan@onepatientonecure.org
Manisha B. Sharma
Manisha is a results-driven product leader with extensive experience in developing and launching AI-powered solutions within the global healthcare sector. Her career spans leadership roles at industry-leading organizations, where she has consistently transformed complex data into actionable insights, optimized clinical workflows, and accelerated the adoption of cutting-edge technologies. As Senior Director of AI Products at Xsolis, Manisha oversees a portfolio of AI-driven solutions that enhance clinical and financial outcomes for healthcare providers and payers. Her expertise in product strategy, data management, and healthcare operations directly supports One Patient One Cure’s mission to bring life-saving innovations to patients worldwide.
Email: manisha.sharma@onepatientonecure.org